Chemokines and disease - PubMed (original) (raw)

Review

doi: 10.1038/84209.

Affiliations

• PMID: 11175802
• DOI: 10.1038/84209

Review

Chemokines and disease

C Gerard et al. Nat Immunol. 2001 Feb.

Abstract

We examine here several diseases that are associated with inappropriate activation of the chemokine network. Detailed comment has been restricted to pathological states for which there are compelling data either from clinical observations or animal models. These include cardiovascular disease, allergic inflammatory disease, transplantation, neuroinflammation, cancer and HIV-associated disease. Discussion focuses on therapeutic directions in which the rapidly evolving chemokine field appears to be headed.

PubMed Disclaimer

Similar articles

• [Blockade of chemokines in chronic inflammatory diseases].
  Haringman JJ, Tak PP. Haringman JJ, et al. Ned Tijdschr Geneeskd. 2004 Sep 4;148(36):1760-4. Ned Tijdschr Geneeskd. 2004. PMID: 15495938 Review. Dutch.
• [Role of chemokine receptors in allergic inflammation and new potential of treatment of bronchial asthma].
  D'Ambrosio D. D'Ambrosio D. Recenti Prog Med. 2002 Jun;93(6):346-50. Recenti Prog Med. 2002. PMID: 12085712 Italian.
• The chemokine system in neuroinflammation: an update.
  Ransohoff RM. Ransohoff RM. J Infect Dis. 2002 Dec 1;186 Suppl 2:S152-6. doi: 10.1086/344266. J Infect Dis. 2002. PMID: 12424691 Review.
• Multiple sclerosis: autoimmune disease.
  Chinen A, Yokoyama M. Chinen A, et al. Hawaii Med J. 1971 Nov-Dec;30(6):464-71. Hawaii Med J. 1971. PMID: 5156962 No abstract available.

Cited by

• An overview of the role of chemokine CX3CL1 (Fractalkine) and CX3C chemokine receptor 1 in systemic sclerosis.
  Pezeshkian F, Shahriarirad R, Mahram H. Pezeshkian F, et al. Immun Inflamm Dis. 2024 Oct;12(10):e70034. doi: 10.1002/iid3.70034. Immun Inflamm Dis. 2024. PMID: 39392260 Free PMC article. Review.
• The chemokine receptor CCR8 is not a high-affinity receptor for the human chemokine CCL18.
  Hussain K, Lim HD, Devkota SR, Kemp-Harper BK, Lane JR, Canals M, Pease JE, Stone MJ. Hussain K, et al. PLoS One. 2024 Sep 11;19(9):e0305312. doi: 10.1371/journal.pone.0305312. eCollection 2024. PLoS One. 2024. PMID: 39259753 Free PMC article.
• A CCL2/MCP-1 antagonist attenuates fibrosis of the infrapatellar fat pad in a rat model of arthritis.
  Yoshimura H, Nakagawa Y, Muneta T, Koga H. Yoshimura H, et al. BMC Musculoskelet Disord. 2024 Aug 29;25(1):674. doi: 10.1186/s12891-024-07737-y. BMC Musculoskelet Disord. 2024. PMID: 39210303 Free PMC article.
• Construction of programmed time-released multifunctional hydrogel with antibacterial and anti-inflammatory properties for impaired wound healing.
  Peng Y, Guo Y, Ge X, Gong Y, Wang Y, Ou Z, Luo G, Zhan R, Zhang Y. Peng Y, et al. J Nanobiotechnology. 2024 Mar 23;22(1):126. doi: 10.1186/s12951-024-02390-y. J Nanobiotechnology. 2024. PMID: 38519957 Free PMC article.
• Analysis of genes characterizing chronic thrombosis and associated pathways in chronic thromboembolic pulmonary hypertension.
  Zhan S, Wang L, Wang W, Li R. Zhan S, et al. PLoS One. 2024 Mar 7;19(3):e0299912. doi: 10.1371/journal.pone.0299912. eCollection 2024. PLoS One. 2024. PMID: 38451963 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations